Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04564703
Title Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Myeloma Network
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD | ITA | GRC | FRA


No variant requirements are available.